BCL2L1 and glioblastoma: CTGF expression resulted in the induction of various anti-apoptotic proteins BCL-xl, Survivin and Flip in GBM, resulting in an aggressive phenotype as the cells became refractory to various chemotherapeutic agents and other adverse conditions54.